| MeSH term | MeSH ID | Detail |
|---|---|---|
| Uremia | D014511 | 33 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Neoplasms, Experimental | D009374 | 10 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gautam J et al. | An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. | 2016 | J. Pharm. Pharmacol. | pmid:27265669 |
| Bumdelger B et al. | Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. | 2016 | PLoS ONE | pmid:26783750 |
| Owen S et al. | Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. | 2016 | Int. J. Oncol. | pmid:26781475 |
| Maser RE et al. | Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. | 2016 | J. Diabetes Complicat. | pmid:26775555 |
| Melchiorre D et al. | Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. | 2016 | Haematologica | pmid:26494839 |
| Wang HL et al. | Protein biomarkers and microbial profiles in peri-implantitis. | 2016 | Clin Oral Implants Res | pmid:26424287 |
| Kainuma S et al. | Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. | 2016 | Mol Med Rep | pmid:26935864 |
| Bolamperti S et al. | Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. | 2016 | Biomed Res Int | pmid:27999816 |
| Li Y et al. | Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. | 2016 | J. Genet. | pmid:27994198 |
| Gómez-Vaquero C et al. | Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. | 2016 | PLoS ONE | pmid:27911913 |
| Zhang L et al. | Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis. | 2016 | Cell. Physiol. Biochem. | pmid:27898403 |
| Biscetti F et al. | RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. | 2016 | Eur Rev Med Pharmacol Sci | pmid:27874938 |
| Liu FQ et al. | Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. | 2016 | Circ. J. | pmid:27867157 |
| Kim CS et al. | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. | 2016 | PLoS ONE | pmid:27855207 |
| Kassem A et al. | Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. | 2016 | PLoS ONE | pmid:27311019 |
| Wang JH et al. | Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. | 2016 | Medicine (Baltimore) | pmid:27310953 |
| Yamada C et al. | TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts. | 2016 | Int. J. Oncol. | pmid:27279422 |
| He M et al. | Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. | 2016 | Mol Med Rep | pmid:27277157 |
| Ye C et al. | [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27266195 |
| Bernardi S et al. | Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. | 2016 | Biomed Res Int | pmid:27200369 |